Storia in 1 fonti

Exclusive: Spot Bio launches with $40M to study mRNA therapy for muscular dystrophy

Spot Biosystems emerges from stealth with $40M raised, reporting early human data showing dystrophin restoration in two children with Duchenne muscular dystrophy.

Raccontata da

endpoints.news

Timeline cronologica

mercoledì 17 giugno 2026·endpoints.news
Exclusive: Spot Bio launches with $40M to study mRNA therapy for muscular dystrophy
Spot Biosystems emerges from stealth with $40M raised, reporting early human data showing dystrophin restoration in two children with Duchenne muscular dystrophy.